Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | cysteine peptidase, Clan CA, family C2, putative | 0.0113 | 0.1511 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0095 | 0.1227 | 0.0923 |
Echinococcus granulosus | tumor susceptibility gene 101 protein | 0.0082 | 0.1013 | 0.8039 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.017 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0638 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0152 | 0.2148 | 0.4209 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0095 | 0.1227 | 0.7969 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0133 | 0.0271 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0095 | 0.1227 | 0.2284 |
Echinococcus multilocularis | tumor susceptibility gene 101 protein | 0.0082 | 0.1013 | 0.8039 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0638 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0047 | 0.0451 | 0.0121 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0113 | 0.1511 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0071 | 0.0845 | 0.5235 |
Schistosoma mansoni | tsg101-related | 0.0068 | 0.0791 | 0.6018 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0054 | 0.056 | 0.3904 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0095 | 0.1227 | 0.0923 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.017 | 0.0404 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0095 | 0.1227 | 0.0923 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0071 | 0.0845 | 0.6506 |
Trypanosoma brucei | calpain-like protein, putative | 0.0113 | 0.1511 | 1 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0113 | 0.1511 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0113 | 0.1511 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0047 | 0.0451 | 0.0121 |
Brugia malayi | Temporarily assigned gene name protein 44 | 0.0027 | 0.0133 | 0.0271 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0638 | 1 | 1 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0312 | 0.4727 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.017 | 0.0404 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0113 | 0.1511 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0054 | 0.056 | 0.0891 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0095 | 0.1227 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0054 | 0.056 | 0.3904 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0054 | 0.056 | 0.3904 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0113 | 0.1511 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0095 | 0.1227 | 1 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0113 | 0.1511 | 1 |
Loa Loa (eye worm) | tumor suppressor | 0.0324 | 0.4921 | 1 |
Schistosoma mansoni | tsg101-related | 0.0068 | 0.0791 | 0.6018 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0071 | 0.0845 | 0.6506 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0638 | 1 | 0.5 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0113 | 0.1511 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0071 | 0.0845 | 0.6506 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0113 | 0.1511 | 1 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0095 | 0.1227 | 1 |
Brugia malayi | hypothetical protein | 0.0082 | 0.1013 | 0.2058 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0071 | 0.0845 | 1 |
Onchocerca volvulus | 0.0152 | 0.2148 | 1 | |
Brugia malayi | hypothetical protein | 0.0152 | 0.2148 | 0.4366 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0095 | 0.1227 | 0.0923 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0113 | 0.1511 | 1 |
Schistosoma mansoni | tsg101-related | 0.0056 | 0.059 | 0.4175 |
Trypanosoma brucei | calpain, putative | 0.0113 | 0.1511 | 1 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0312 | 0.4727 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.017 | 0.0076 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0638 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0095 | 0.1227 | 0.0923 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0095 | 0.1227 | 0.0677 |
Trypanosoma brucei | hypothetical protein | 0.0113 | 0.1511 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0071 | 0.0845 | 0.6506 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.017 | 0.0404 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0638 | 1 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0054 | 0.056 | 0.1138 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0095 | 0.1227 | 0.2493 |
Schistosoma mansoni | kinase | 0.0048 | 0.0471 | 0.3093 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0054 | 0.056 | 0.3904 |
Trypanosoma cruzi | calpain cysteine peptidase, putative | 0.0113 | 0.1511 | 1 |
Brugia malayi | tumor suppressor. | 0.0324 | 0.4921 | 1 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0638 | 1 | 1 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0095 | 0.1227 | 0.7969 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0054 | 0.056 | 0.3904 |
Trypanosoma brucei | variant surface glycoprotein (VSG), putative | 0.0113 | 0.1511 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.017 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0638 | 1 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0638 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0095 | 0.1227 | 0.0923 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0095 | 0.1227 | 0.7969 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0054 | 0.056 | 0.3904 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0054 | 0.056 | 0.3904 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0638 | 1 | 1 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0113 | 0.1511 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0113 | 0.1511 | 1 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0113 | 0.1511 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0095 | 0.1227 | 0.0923 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.017 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0638 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.017 | 0.0404 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0312 | 0.4727 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.1013 | 0.1836 |
Brugia malayi | hypothetical protein | 0.003 | 0.017 | 0.0345 |
Trypanosoma brucei | polo-like protein kinase | 0.0095 | 0.1227 | 0.7969 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.